Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.37 is 56% below its 5-year average of -2.16, near the low end of its 5-year range (-3.37–-1.69).
29.62% below its 12-month average of -2.60.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.77.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-3.37
EARNINGS PER SHARE (EPS) AVG TTM
-2.60
EARNINGS PER SHARE (EPS) AVG 3Y
-2.33
EARNINGS PER SHARE (EPS) AVG 5Y
-2.16
EARNINGS PER SHARE (EPS) AVG 10Y
-1.95
EARNINGS PER SHARE (EPS) AVG 15Y
-1.51
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-29.62%
CURRENT VS 3Y AVG
-44.79%
CURRENT VS 5Y AVG
-55.90%
CURRENT VS 10Y AVG
-72.66%
CURRENT VS 15Y AVG
-123.00%
CURRENT VS 20Y AVG
N/A
Kura Oncology, Inc.
Market Cap
$925.92M
Earnings Per Share (EPS)
-3.37
TTM Avg
-2.60
3Y Avg
-2.33
5Y Avg
-2.16
Market Cap
$923.17M
Earnings Per Share (EPS)
-3.85
TTM Avg
-2.71
3Y Avg
-1.96
5Y Avg
-1.55
Market Cap
$918.97M
Earnings Per Share (EPS)
-1.76
TTM Avg
-1.29
3Y Avg
-1.36
5Y Avg
-1.36
Market Cap
$936.78M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.94
3Y Avg
-1.94
5Y Avg
-1.94
Market Cap
$912.07M
Earnings Per Share (EPS)
0.72
TTM Avg
0.64
3Y Avg
0.54
5Y Avg
0.47
Market Cap
$952.20M
Earnings Per Share (EPS)
-1.05
TTM Avg
-1.23
3Y Avg
-0.94
5Y Avg
-0.94
Market Cap
$957.40M
Earnings Per Share (EPS)
-0.58
TTM Avg
-0.51
3Y Avg
-0.40
5Y Avg
-0.46
Market Cap
$887.93M
Earnings Per Share (EPS)
0.78
TTM Avg
-0.28
3Y Avg
-0.36
5Y Avg
-0.51
Market Cap
$887.32M
Earnings Per Share (EPS)
0.77
TTM Avg
-0.09
3Y Avg
-1.31
5Y Avg
-0.73
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kura Oncology, Inc. (KURA) | $925.92M | -3.37 | -2.60 | -2.33 | -2.16 |
| MoonLake Immunotherapeutics (MLTX)vs › | $923.17M | -3.85 | -2.71 | -1.96 | -1.55 |
| CeriBell, Inc. (CBLL)vs › | $918.97M | -1.76 | -1.29 | -1.36 | -1.36 |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $936.78M | N/A | -1.94 | -1.94 | -1.94 |
| HealthStream, Inc. (HSTM)vs › | $912.07M | 0.72 | 0.64 | 0.54 | 0.47 |
| Aktis Oncology, Inc. (AKTS)vs › | $952.20M | -1.05 | -1.23 | -0.94 | -0.94 |
| Savara Inc. (SVRA)vs › | $957.40M | -0.58 | -0.51 | -0.40 | -0.46 |
| Arbutus Biopharma Corp (ABUS)vs › | $887.93M | 0.78 | -0.28 | -0.36 | -0.51 |
| Bioventus Inc. (BVS)vs › | $887.32M | 0.77 | -0.09 | -1.31 | -0.73 |
| Pacira BioSciences, Inc. (PCRX)vs › | $970.39M | 0.35 | -0.99 | -0.18 | 0.61 |
Trailing EPS (TTM)
$-3.37
Forward EPS (Est.)
$-3.22
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -3.18 |
| 2024-12-31 | -2.02 |
| 2023-12-31 | -2.08 |
| 2022-12-31 | -2.03 |
| 2021-12-31 | -1.97 |
| 2020-12-31 | -1.69 |
| 2019-12-31 | -1.51 |
| 2018-12-31 | -1.72 |
| 2017-12-31 | -1.52 |
| 2016-12-31 | -1.47 |
| 2015-12-31 | -2.28 |
| 2014-12-31 | -2.69 |
| 2013-12-31 | -0.01 |
| 2012-12-31 | -0.01 |
| 2011-12-31 | 0.00 |
| 2010-12-31 | 0.00 |
| 2009-12-31 | 0.00 |
| 2008-12-31 | -0.01 |
